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During antimicrobial drug resistance testing for Vibrio spp. from 
coastal waters of Germany, we identified 4 nontoxigenic, car-
bapenem-resistant V. cholerae isolates. We used whole-ge-
nome sequencing to identify the carbapenemase gene blaVCC-1. 
In addition, a molecular survey showed that more blaVCC-1–har-
boring isolates are present in coastal waters of Germany.
Mangat et al. recently identified a novel ambler class A carbapenemase (VCC-1) in nontoxigenic Vibrio 
cholerae isolated from imported retail shrimp from India 
intended for human consumption in Canada (1). Occur-
rence of blaVCC-1–harboring bacteria in seafood might be 
caused by uptake of V. cholerae in the aquatic environment. 
Lutz et al. reported worldwide distribution of V. cholerae 
non–O1/O139 strains in coastal waters with low salinity 
(2). Some of these strains were associated with wound in-
fections and with diarrheal diseases after ingestion of con-
taminated seafood (3,4).
An antimicrobial resistance survey of potentially patho-
genic Vibrio spp. recovered from coastal waters of Germany 
identified 4 carbapenem-resistant V. cholerae non–O1/O139 
isolates (5). These isolates were detected in the Baltic Sea 
(VN-2997, Eckernförde) and North Sea (VN-2808, Büsum; 
VN-2825, Speicherkoog; VN-2923, unknown). We used 
whole-genome sequencing to examine the genetic basis of 
carbapenem resistance in these strains.
We isolated genomic DNA by using the Easy-DNA 
Kit (Invitrogen, Carlsbad, CA, USA). This DNA was 
used for preparation of libraries by using the Nextera-XT-
DNA Sample Preparation Kit (Illumina Inc., San Diego, 
CA, USA) and sequenced by using an MiSeq-benchtop-
sequencer, MiSeq-Reagent version 2 (300 cycles), and 
two 150-bp paired-end reads (Illumina Inc.). We then 
performed de novo assemblies of reads by using SPAdes 
version 3.5.0 (http://spades.bioinf.spbau.ru/release3.5.0/
manual.html). We deposited sequences in GenBank and 
performed genome annotation by using the NCBI Prokary-
otic Genome Annotation Pipeline (https://www.ncbi.nlm.
nih.gov/genome/annotation_prok/).
We found blaVCC-1 in all isolates on contigs of 2,135 
bp (VN-2825, VN-2997), 2,139 bp (VN-2923), and 2,737 
bp (VN-2808). The blaVCC-1-coding sequences and flank-
ing nucleotide sequences were 100% identical among the 
strains, as determined by sequence alignments. We also 
identified the main characteristics of V. cholerae genomes 
(Table; online Technical Appendix Figure, https://wwwnc.
cdc.gov/EID/article/23/10/16-1625-Techapp1.pdf). Over-
all, the genomes belong to the same multilocus sequence 
type (ST), ST336 (adk 57, gyrB 76, mdh 14, metE 115, 
pntA 18, purM 1, pyrC 101) (6). 
We performed functional studies of the entire blaVCC-1–
harboring region (pVCC-1C, 2.7 kb) and blaVCC-1 gene 
(pVCC-1G, 0.9 kb) of V. cholerae VN-2808 (online Tech-
nical Appendix Figure) by molecular cloning of PCR-am-
plified regions according to standard procedures (7). After 
transformation of Escherichia coli GeneHogs (Invitrogen, 
Darmstadt, Germany) and susceptibility testing for aztre-
onam, imipenem, and meropenem as described (5), both 
constructs showed decreased inhibition zone diameters 
compared with that for E. coli GeneHogs vector. We ob-
served slightly reduced drug susceptibility levels or inter-
mediate resistance levels, as observed in V. cholerae VN-
2808 (online Technical Appendix Figure).
On the basis of these results, we conducted blaVCC-1 
screening of the V. cholerae collection at the German Fed-
eral Institute for Risk Assessment (Berlin, Germany). This 
collection contains 312 toxigenic and nontoxigenic isolates 
from human, environmental, and food origin obtained in 
Europe (n = 218), Africa (n = 20), Asia (n = 18), North 
America (n = 1), South America (n =1), and of unknown 
origin (n = 54) during 1941–2015.
We performed PCR by using primers (blaVCC-1-for-
ward/reverse: 5′-ATCTCTACTTCAACAGCTTTCG/
CCTAGCTGCTTTAGCAATCAC-3′) with denaturation 
at 94°C for 120 s; 35 cycles of denaturation at 94°C for 
15 s, annealing at 53°C for 30 s, and elongation for 210 
s at 72°C; and a final elongation at 72°C for 1 min. This 
testing detected blaVCC-1 in 3 (1.6%) ctx-negative, non–O1/
O139 V. cholerae isolates obtained from waters of the port 
of Husum, Germany, on the North Sea during 2015. Sanger 
sequencing confirmed the presence of blaVCC-1. These 3 
isolates belong to the new multilocus ST516. This type is 
divergent from ST336 only for the novel pyrC 150 variant, 
which was recently deposited in the PubMLST database 
(https://pubmlst.org).
In conclusion, this study showed the presence of 7 
VCC-1 carbapenemase-producing V. cholerae at different 
locations on the coastline of Germany. The blaVCC-1 flanking 1Current affiliation: European Food Safety Authority, Parma, Italy.
genetic sequences were identical in the 4 sequenced V. chol-
erae from Germany and appeared to be different from the 
strain isolated in Canada, which probably originated in In-
dia (online Technical Appendix Figure). This finding sug-
gests that blaVCC-1 was acquired by V. cholerae from a yet 
unknown progenitor on at least 2 occasions. Strains from 
Germany probably belong to the autochthonous microflora 
and represent an environmental reservoir of carbapenem 
resistance in coastal waters. blaVCC-1–encoding V. cholerae 
might be taken up by mussels, shrimps, and fish and then 
enter the food chain.
Because carbapenems are needed for treatment of 
severe infections with multidrug-resistant bacteria in hu-
mans, the presence of bacteria with acquired, and thereby 
potentially transferable, carbapenemases in environments 
near human activities is a major public health concern (8). 
To date, acquired carbapenemases were detected mainly 
in clinical isolates and only rarely in environmental and 
foodborne bacteria (9,10). Exposure of humans to car-
bapenemase-producing pathogenic bacteria by ingestion of 
contaminated food products or by direct contact with con-
taminated water might pose a threat to public health. Our 
findings indicate that surveillance for antimicrobial drug 
resistance should be extended to locations of human activi-
ties and foods of aquatic origin.
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Table. Genome characteristics of 4 carbapenemase-producing Vibrio cholerae isolates from coastal waters of Germany* 
Characteristic 
Isolate 
VN-2808 VN-2825 VN-2923 VN-2997 
No. genes 3,934 3,921 4,040 3,933 
 Coding genes 3,545 3,608 3,650 3,612 
No. CDS  3,813 3,803 3,920 3,814 
 Coding CDS 3,545 3,608 3,650 3,612 
No. RNA genes 121 118 120 119 
No. rRNAs (5S, 16S, 23S) 10, 12, 7 10, 12, 4 10, 11, 7 10, 12, 4 
 Complete rRNAs (5S, 23S) 10, 1 10, 1 10, 1 10, 1 
 Partial rRNAs (16S, 23S) 12, 6 12, 3 11, 6 12, 3 
No. tRNAs 88 88 88 89 
No. noncoding RNAs  4 4 4 4 
No. pseudogenes 268 195 270 202 
 Ambiguous residues 0 0 0 0 
 Frameshifted 39 37 40 37 
 Incomplete 220 144 221 152 
 Internal stop 20 25 22 23 
 Multiple problems 11 11 13 10 
No. predicted prophages 5 2 5 2 
 Intact 2 0 1 0 
 Incomplete 3 1 4 2 
 Questionable 0 1 0 0 
No. plasmids ND ND ND ND 
Antibiotic resistance     
 β-lactam† blaVCC-1 (100%) blaVCC-1 (100%) blaVCC-1 (100%) blaVCC-1 (100%) 
MLST type ST336 ST336 ST336 ST336 
GenBank information     
 Bioproject no. PRJNA331077 PRJNA331078 PRJNA331079 PRJNA331080 
 Biosample no. SAMN05437226 SAMN0537225 SAMN0537224 SAMN0537223 
 Accession no. MCBB00000000 MCBA00000000 MCAZ00000000 MCAY00000000 
*In silico analyses were conducted by using the services of the NCB Prokaryotic Genome Annotation Pipeline 
(https://www.ncbi.nlm.nih.gov/genome/annotation_prok/), the Center for Genomic Epidemiology (http://.genomicepidemiology.org), and PHAST 
(http://www.phast.wishartlab.com/). CDS, coding DNA sequence; MLST, multilocus sequencing typing; ND, not determined; ST, sequence type. 
†Percentage values indicate level of nucleotide similarity against the reference gene (GenBank accession no. KT818596). 
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We isolated East/Central/South African genotype chikun-
gunya virus during the 2016 epidemic in Rio de Janeiro, 
Brazil. Genome sequencing revealed unique mutations in 
the nonstructural protein 4 (NSP4-A481D) and envelope 
protein 1 (E1-K211T). Moreover, all Brazil East/Central/
South isolates shared the exclusive mutations E1-M407L 
and E2-A103T.
Chikungunya virus (CHIKV) is an alphavirus (family Togaviridae) transmitted by Aedes aegypti and Ae. al-
bopictus mosquitoes. Chikungunya fever is characterized 
by fever, intense polyarthralgia, headache, joint swelling, 
and rash. Polyarthralgia can persist for several months 
after the acute phase (1). The 3 main CHIKV genotypes 
are Asian, West African, and East/Central/South African 
(ECSA), in addition to the ECSA-derived Indian Ocean lin-
eage (1). Genetic analysis of CHIKV genomes has shown 
substitutions in envelope (E) 1 and E2 proteins that affect 
virus adaptability to Aedes mosquitoes. For example, E1-
K211E and E2-V264A mutations have been reported to 
increase CHIKV fitness in Ae. aegypti (2), whereas E1-
A226V and E2-L210Q mutations have been associated 
with improved adaptability to Ae. albopictus mosquitoes 
(3,4). The E1-T98A mutation enhances the vector-adapt-
ability effect of E1-A226V, which is otherwise restricted by 
epistatic interactions between E1-98T and E1-A226V (4).
Autochthonous transmission of CHIKV (Asian geno-
type) in Brazil first occurred in 2014 in Oiapoque, Brazil-
ian Amazon, 1 year after CHIKV introduction in the Ca-
ribbean (1). Since late 2014, autochthonous cases of the 
ECSA genotype have been reported in northeastern Brazil 
(1), a region of sustained cocirculation of dengue virus 
(DENV) for decades and the epicenter of recent Zika vi-
rus outbreaks (5).
Until late 2015, only a few imported cases of CHIKV 
(Asian genotype) had been reported in Rio de Janeiro (6). 
However, in December 2015, ten autochthonous CHIKV 
transmissions were reported, followed by an increase to 
11,602 by August 2016, which accounted for 88.9% of re-
ported cases in the state. Of these, 1,868 have been labora-
tory confirmed as CHIKV, leading to the highest incidence 
of CHIKV infection in southeastern Brazil (7). Neverthe-
less, the CHIKV genotype associated with the epidemic in 
Rio de Janeiro remains unknown.
On March 16, 2016, the emergency laboratory of the 
Brazilian Army Institute of Biology at Rio de Janeiro col-
lected blood samples from a 16-year-old girl and a 29-year-
old man who sought care at the associated military hospi-
tal. The patients had fever (40°C) for 24–48 h, debilitating 
polyarthralgia, and myalgia. The man also had exanthema 
and itching. The diagnostic hypotheses were Zika, den-
gue, or chikungunya, given their similar clinical symptoms 
(5). Laboratory findings were unremarkable except for 
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